TL;DR: UnitedHealthcare modified its Medicare Advantage platelet-rich plasma coverage policy (policy code: platelet-rich-plasma-therapies), effective November 2, 2025. Billing teams using CPT 0232T, G0460, G0465, or P9020 need to confirm which coverage pathway governs each claim before submitting.
UnitedHealthcare updated its Medicare Advantage medical policy for platelet-rich plasma (PRP) therapies. The policy now makes explicit which coverage authority applies to each indication — CMS National Coverage Determinations, Local Coverage Determinations, or UHC's own commercial policy. If your practice bills PRP for chronic wounds or musculoskeletal conditions, this layered framework determines whether you get paid. Understanding which document controls each claim is the difference between reimbursement and a denial.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | UnitedHealthcare |
| Policy | Platelet Rich Plasma Therapies – Medicare Advantage Medical Policy |
| Policy Code | platelet-rich-plasma-therapies |
| Change Type | Modified |
| Effective Date | 2025-11-02 |
| Impact Level | High |
| Specialties Affected | Wound care, orthopedics, podiatry, physical medicine & rehabilitation, sports medicine |
| Key Action | Confirm the governing coverage authority (NCD, LCD, or UHC commercial policy) for every PRP claim before billing |
UnitedHealthcare Platelet-Rich Plasma Coverage Criteria and Medical Necessity Requirements 2025
The UnitedHealthcare platelet-rich plasma coverage policy operates on three tiers. Which tier controls your claim depends entirely on the indication and your geographic location.
Tier 1 — CMS NCD 270.3 (Diabetic Wounds)
For autologous PRP used on chronic non-healing diabetic wounds, CMS NCD 270.3 (Blood-Derived Products for Chronic Non-Healing Wounds) governs. Bill G0465 for this indication. UHC defers to the NCD here — your medical necessity documentation must satisfy NCD 270.3's criteria, not a UHC-specific checklist.
Tier 2 — Local Coverage Determinations (Musculoskeletal and Non-Diabetic Wounds)
For musculoskeletal injuries and joint conditions, and for non-diabetic chronic non-healing wounds not covered by NCD 270.3, UHC requires compliance with applicable LCDs and Local Coverage Articles (LCAs). This is where regional variation creates billing complexity. Your Medicare Administrative Contractor (MAC) determines which LCD applies to your state or territory. Bill CPT 0232T for PRP injections into musculoskeletal sites, and G0460 for non-diabetic chronic wound applications.
The real issue here: not every state has an applicable LCD. If your MAC has no active LCD for a given PRP indication, the coverage pathway shifts.
Tier 3 — UHC Commercial Policy (No LCD/LCA Coverage)
For states and territories with no applicable LCD or LCA, and for indications not addressed by NCD 270.3, UHC points to its own commercial medical policy: Prolotherapy and Platelet Rich Plasma Therapies. This is the fallback — and it's important because the commercial policy may have different medical necessity criteria than what your billing team expects from a Medicare Advantage plan.
If you bill PRP in a state without an active LCD, you're operating under UHC's commercial criteria. Know that document. Your compliance officer should have it on file.
UnitedHealthcare Platelet-Rich Plasma Exclusions and Non-Covered Indications
P9020 — "Platelet rich plasma, each unit" — carries an explicit non-covered designation in this policy. This code appears in the policy data with a Non-Covered flag. Don't bill P9020 expecting UHC Medicare Advantage reimbursement. If your billing team has been using P9020 as a line item for the PRP product itself (separate from the application), stop now. You will get a claim denial.
This is a common billing mistake in PRP claims — separating the product code from the procedure code and billing both. The covered codes (G0460, G0465, and 0232T) bundle preparation, harvesting, and application into the procedure. P9020 is not a payable add-on under this policy.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Chronic non-healing diabetic wounds | Covered per NCD 270.3 | G0465 | Medical necessity criteria governed by CMS NCD 270.3; UHC defers to NCD |
| Non-diabetic chronic non-healing wounds (where LCD/LCA exists) | Covered per applicable LCD/LCA | G0460 | Must comply with MAC-specific LCD/LCA where applicable |
| Musculoskeletal injuries and joint conditions (where LCD/LCA exists) | Covered per applicable LCD/LCA | CPT 0232T | Must comply with MAC-specific LCD/LCA; includes image guidance, harvesting, and preparation |
| Non-diabetic chronic wounds or indications with no applicable LCD/LCA | Covered per UHC Commercial Policy | G0460, CPT 0232T | Refer to UHC's Prolotherapy and Platelet Rich Plasma Therapies commercial policy |
| Platelet rich plasma product (unit billing) | Non-Covered | P9020 | Explicitly non-covered; do not bill separately |
UnitedHealthcare Platelet-Rich Plasma Billing Guidelines and Action Items 2025
This policy was effective November 2, 2025. If you haven't already audited your PRP claims under UHC Medicare Advantage, do it now. Here's what your billing team needs to do:
| # | Action Item |
|---|---|
| 1 | Identify your MAC and confirm which LCDs apply to your state. Go to the CMS LCD database and search by your MAC's jurisdiction. For musculoskeletal PRP (CPT 0232T) and non-diabetic wound PRP (G0460), the applicable local coverage determination controls medical necessity. If no LCD exists for your state, you're under UHC's commercial policy — not the LCD framework. |
| 2 | Pull the UHC commercial Prolotherapy and Platelet Rich Plasma Therapies policy now. You need the specific medical necessity criteria from that document if you operate in a non-LCD state or territory. This is not optional — it's the governing document for a significant portion of your PRP claims. |
| 3 | Remove P9020 from your charge capture for UHC Medicare Advantage. This code is explicitly non-covered. Any claim with P9020 on a UHC Medicare Advantage plan will deny. Update your charge master to flag or block P9020 for this payer before your next billing cycle. |
| 4 | Audit prior authorization requirements for CPT 0232T by plan. This policy doesn't specify prior authorization requirements at the policy level — those are set at the plan level. Check UHC's provider portal for the specific Medicare Advantage plan your patient carries. Some plans require prior auth for PRP procedures even when the LCD supports coverage. A covered indication doesn't mean prior auth is waived. |
| 5 | Align your documentation to the correct governing document. For G0465 diabetic wound claims, your notes must satisfy NCD 270.3 criteria. For LCD-governed claims, documentation must meet your MAC's specific LCD requirements. For commercial-policy-governed claims, documentation must satisfy UHC's own criteria. Billing all three pathways with identical documentation is a fast route to denials and audit exposure. |
| 6 | Talk to your compliance officer if your practice spans multiple states. If you bill UHC Medicare Advantage across multiple MAC jurisdictions, your applicable LCDs will differ by state. Managing that variation requires a clear internal protocol. If you don't have one, get one built before Q1 2026. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Platelet-Rich Plasma Therapies Under platelet-rich-plasma-therapies
Covered CPT Codes (When Selection Criteria Are Met)
| Code | Type | Description |
|---|---|---|
| 0232T | CPT | Injection(s), platelet rich plasma, any site, including image guidance, harvesting and preparation |
Covered HCPCS Codes (When Selection Criteria Are Met)
| Code | Type | Description | Governing Authority |
|---|---|---|---|
| G0460 | HCPCS | Autologous platelet rich plasma (PRP) or other blood-derived product for nondiabetic chronic wounds/ulcers | Applicable LCD/LCA or UHC commercial policy (where no LCD exists) |
| G0465 | HCPCS | Autologous platelet rich plasma (PRP) or other blood-derived product for diabetic chronic wounds/ulcers | CMS NCD 270.3 |
Non-Covered Codes
| Code | Type | Description | Reason |
|---|---|---|---|
| P9020 | HCPCS | Platelet rich plasma, each unit | Explicitly designated Non-Covered under this policy |
Key ICD-10-CM Diagnosis Codes
The policy data does not list specific ICD-10 codes. Your applicable diagnosis codes are determined by the governing LCD, NCD 270.3, or UHC's commercial policy. Pull diagnosis requirements from each of those source documents based on the coverage pathway for each claim.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.